Completed PHASE2 INTERVENTIONAL 2-arm NCT03365999

Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.

Comparative Study of the Efficiency of Oral Tranexamic Tcid vs. Oral Tminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement. A Prospective, Randomized, Double Blinded Controlled Clinical Trial.

Sponsor: Universidad Autonoma de Nuevo Leon

Conditions Blood Clot Blood Loss Knee Osteoarthritis Transfusion Related Complication

Interventions Oral Aminocaproic Acid Oral Tranexamic Acid

Updated 7 times since 2017 Last updated: Jul 26, 2019 Started: Oct 15, 2017 Primary completion: Jul 1, 2019 Completion: Jul 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03365999, this PHASE2 trial focuses on Blood Clot and Blood Loss and remains completed. Sponsored by Universidad Autonoma de Nuevo Leon, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Aug 2019 — Jan 2021 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Dec 2018 — Aug 2019 [monthly]

Recruiting PHASE2

▶ Show 2 earlier versions

Jun 2018 — Dec 2018 [monthly]

Recruiting PHASE2
Dec 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Oct 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidad Autonoma de Nuevo Leon

Data source: Universidad Autonoma de Nuevo Leon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Monterrey, Mexico